Enliven Therapeutics (ELVN) Tax Rate (2024 - 2025)
Enliven Therapeutics (ELVN) posted Tax Rate of 0.94% for Q2 2024.
Enliven Therapeutics (ELVN) Tax Rate (2024 - 2025) Analysis & Trends
Enliven Therapeutics has reported Tax Rate for 1 years, with the latest figure at 0.94% in Q2 2024.
- Quarterly Tax Rate changed N/A year-over-year to 0.94% in Q2 2024, while the trailing twelve-month figure through Jun 2025 was 0.2% (changed N/A YoY) and the FY2024 annual result came in at 0.13%, changed N/A from the prior year.
- Tax Rate was little changed at 0.94% in Q2 2024 per ELVN's latest filing.
- Over five years, Tax Rate peaked at 0.94% in Q2 2024 and troughed at 0.94% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Enliven Therapeutics | 4.31 Bn | 3.41 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.29% |
| Dec 31, 2025 | 63.29% |
| Dec 31, 2025 | 63.29% |
| Dec 31, 2024 | 70.07% |
| Dec 31, 2024 | 70.07% |
| Dec 31, 2024 | 70.07% |
| Jun 30, 2024 | -0.94% |
| Jun 30, 2024 | -0.94% |
| Jun 30, 2024 | -0.94% |